The India diagnostic testing market size reached USD 11.38 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 26.73 Billion by 2033, exhibiting a growth rate (CAGR) of 9.22% during 2025-2033. The market is experiencing significant growth due to increasing healthcare awareness, rising prevalence of chronic diseases, and advancements in testing technologies. The demand for both in-lab and point-of-care diagnostics is expanding, driven by government initiatives and private sector investments. This growth is further supported by innovations in molecular and genetic testing, influencing the India diagnostic testing market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 11.38 Billion |
Market Forecast in 2033 | USD 26.73 Billion |
Market Growth Rate 2025-2033 | 9.22% |
Advancements in Testing Technology
Technological advancements in tests like molecular diagnostics, genetic tests, and Polymerase Chain Reaction are transforming the India diagnostic testing market. Molecular diagnostics enable detecting diseases at a genetic level and facilitating more accurate and early disease detection for cancers, infections, and genetic illnesses. For instance, in May 2024, MolBio Diagnostics, a leading molecular diagnostics firm, aims to enhance its global presence and launch new products in 2024 after achieving Rs 850 crore in revenue. CEO Sriram Natarajan highlighted plans for hepatitis C and HPV tests, TB innovations, and collaborations in women’s health through AI-driven technologies and partnerships. Genetic testing is increasingly popular, providing information on genetic diseases and personalized medicine, resulting in customized treatment plans. PCR technology, a versatile tool for the amplification of minute DNA or RNA samples, is a critical tool used to detect infectious diseases such as COVID-19, tuberculosis, and other viral infections with great accuracy. Such developments greatly enhance testing accuracy and speed, minimizing diagnostic errors and delivering quicker results. The improved reliability and effectiveness of these technologies are creating demand for sophisticated diagnostic solutions, thereby increasing the overall size of the diagnostic testing market in India.
Rising Demand for Point-of-Care Testing
Point-of-care (POC) testing is gaining significant momentum in India due to its ability to deliver quick, accurate, and cost-effective results outside of traditional clinical settings. The increasing adoption of POC diagnostic devices allows healthcare providers to conduct tests at the patient’s location, whether at home, in remote areas, or in healthcare facilities, reducing the need for laboratory visits. For instance, in January 2023, Cipla introduced Cippoint, a point-of-care testing device designed to provide quick diagnostic results for several conditions, such as heart problems, diabetes, and infectious diseases. This device, which has received approval under the European In-Vitro Diagnostic Device Directive, seeks to improve healthcare accessibility, particularly in rural regions, thereby facilitating accurate diagnosis and treatment. This is especially beneficial in rural areas where access to healthcare infrastructure can be limited. Devices such as glucose meters, rapid antigen tests, and portable ECG monitors enable timely diagnosis of conditions like diabetes, infections, and heart diseases. The convenience and speed of POC testing enhance patient outcomes, as early intervention is possible. With advancements in technology and the government’s focus on improving healthcare accessibility, POC testing is contributing to the India diagnostic testing market growth by expanding the reach of healthcare services and providing accessible, real-time results.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on test type, technology, sample type, mode of testing, application and end user.
Test Type Insights:
The report has provided a detailed breakup and analysis of the market based on the test type. This includes laboratory testing, point-of-care testing (POCT), imaging diagnostics, molecular diagnostics, and others.
Technology Insights:
A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes immunoassay-based, PCR-based, next gen sequencing, spectroscopy-based, chromatography-based, microfluidics, and others.
Sample Type Insights:
A detailed breakup and analysis of the market based on the sample type have also been provided in the report. This includes blood, urine, saliva, sweat, hair, and others.
Mode of Testing Insights:
A detailed breakup and analysis of the market based on the mode of testing have also been provided in the report. This includes prescription based testing and OTC testing.
Application Insights:
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes oncology, cardiology, orthopedics, gastroenterology, gynecology, neurology, odontology, others.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, diagnostic centers, ambulatory surgical centers (ASCs), specialty clinics, homecare, blood banks, research labs and institutes, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India and West India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Test Types Covered | Laboratory Testing, Point-of-Care Testing (POCT), Imaging Diagnostics, Molecular Diagnostics, Others |
Technologies Covered | Immunoassay-Based, PCR-Based, Next Gen Sequencing, Spectroscopy-Based, Chromatography-Based, Microfluidics, Others |
Sample Types Covered | Blood, Urine, Saliva, Sweat, Hair, Others |
Modes of Testing Covered | Prescription Based Testing, OTC Testing |
Applications Covered | Oncology, Cardiology, Orthopedics, Gastroenterology, Gynecology, Neurology, Odontology, Others |
End User Covered | Hospitals, Diagnostic Centers, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Homecare, Blood Banks, Research Labs and Institutes, Others |
Regions Covered | North India, South India, East India, West India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: